XML 19 R4.htm IDEA: XBRL DOCUMENT v3.19.1
Consolidated Statements of Comprehensive Loss - USD ($)
shares in Thousands, $ in Thousands
6 Months Ended 12 Months Ended
Dec. 31, 2018
Jun. 30, 2018
Jun. 30, 2017
Jun. 30, 2016
Revenues:        
Total revenues $ 2,928 $ 2,961 $ 7,539 $ 1,620
Operating expenses:        
Research and development 10,412 16,178 14,880 14,381
Sales and marketing 8,174 1,512 0 0
General and administrative 8,901 11,545 11,235 9,013
Total operating expenses 27,487 29,235 26,115 23,394
Operating loss (24,559) (26,274) (18,576) (21,774)
Interest and other income, net 367 101 91 72
Interest expense (1,642) (720) 0 0
Change in fair value of derivative liability (18,886) (26,278) 0 0
Loss before income taxes (44,720) (53,171) (18,485) (21,702)
Income tax benefit 0 0 0 155
Net loss $ (44,720) $ (53,171) $ (18,485) $ (21,547)
Net loss per share:        
Basic and diluted $ (0.53) $ (1.15) $ (0.52) $ (0.68)
Weighted average common shares outstanding:        
Basic and diluted 85,057 46,226 35,344 31,623
Net loss $ (44,720) $ (53,171) $ (18,485) $ (21,547)
Other comprehensive income (loss):        
Foreign currency translation adjustments 1 5 (21) (96)
Net unrealized gain on marketable securities 0 0 2 3
Other comprehensive income (loss) 1 5 (19) (93)
Comprehensive loss (44,719) (53,166) (18,504) (21,640)
Collaborative Research and Development [Member]        
Revenues:        
Total revenues 1,883 1,343 6,569 398
Royalty Income [Member]        
Revenues:        
Total revenues $ 1,045 $ 1,618 $ 970 $ 1,222